These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
654 related articles for article (PubMed ID: 18452214)
1. Sentinel lymph node micrometastasis may predict non-sentinel involvement in cutaneous melanoma patients. Glumac N; Hocevar M; Zadnik V; Snoj M J Surg Oncol; 2008 Jul; 98(1):46-8. PubMed ID: 18452214 [TBL] [Abstract][Full Text] [Related]
2. Prediction of nonsentinel lymph node involvement in patients with a positive sentinel lymph node in malignant melanoma. Page AJ; Carlson GW; Delman KA; Murray D; Hestley A; Cohen C Am Surg; 2007 Jul; 73(7):674-8; discussion 678-9. PubMed ID: 17674939 [TBL] [Abstract][Full Text] [Related]
3. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection. Debarbieux S; Duru G; Dalle S; Béatrix O; Balme B; Thomas L Br J Dermatol; 2007 Jul; 157(1):58-67. PubMed ID: 17501957 [TBL] [Abstract][Full Text] [Related]
4. Validation of a scoring system to predict non-sentinel lymph node metastasis in melanoma. Cadili A; McKinnon G; Wright F; Hanna W; Macintosh E; Abhari Z; Dabbs K J Surg Oncol; 2010 Mar; 101(3):191-4. PubMed ID: 20039281 [TBL] [Abstract][Full Text] [Related]
5. Histological features of melanoma sentinel lymph node metastases associated with status of the completion lymphadenectomy and rate of subsequent relapse. Govindarajan A; Ghazarian DM; McCready DR; Leong WL Ann Surg Oncol; 2007 Feb; 14(2):906-12. PubMed ID: 17136471 [TBL] [Abstract][Full Text] [Related]
6. Is completion lymphadenectomy after a positive sentinel lymph node biopsy for cutaneous melanoma always necessary? Elias N; Tanabe KK; Sober AJ; Gadd MA; Mihm MC; Goodspeed B; Cosimi AB Arch Surg; 2004 Apr; 139(4):400-4; discussion 404-5. PubMed ID: 15078708 [TBL] [Abstract][Full Text] [Related]
7. Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma. Sabel MS; Griffith K; Sondak VK; Lowe L; Schwartz JL; Cimmino VM; Chang AE; Rees RS; Bradford CR; Johnson TM J Am Coll Surg; 2005 Jul; 201(1):37-47. PubMed ID: 15978442 [TBL] [Abstract][Full Text] [Related]
8. Prediction of nonsentinel lymph node metastasis in malignant melanoma. Cadili A; Smylie M; Danyluk J; Dabbs K J Surg Res; 2009 Jun; 154(2):324-9. PubMed ID: 19101696 [TBL] [Abstract][Full Text] [Related]
9. Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients. Roka F; Mastan P; Binder M; Okamoto I; Mittlboeck M; Horvat R; Pehamberger H; Diem E Eur J Surg Oncol; 2008 Jan; 34(1):82-8. PubMed ID: 17360144 [TBL] [Abstract][Full Text] [Related]
10. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma. Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755 [TBL] [Abstract][Full Text] [Related]
11. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3). Nowecki ZI; Rutkowski P; Michej W Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535 [TBL] [Abstract][Full Text] [Related]
12. The analysis of the outcomes and factors related to iliac-obturator involvement in cutaneous melanoma patients after lymph node dissection due to positive sentinel lymph node biopsy or clinically detected inguinal metastases. Zdzienicki M; Rutkowski P; Nowecki ZI; van Akkooi AC; Michej W; Dziewirski W; Świtaj T; Pieńkowski A; Sałamacha M; Bylina E; Eggermont AM Eur J Surg Oncol; 2013 Mar; 39(3):304-10. PubMed ID: 23298828 [TBL] [Abstract][Full Text] [Related]
13. Size of sentinel node metastases predicts other nodal disease and survival in malignant melanoma. Pearlman NW; McCarter MD; Frank M; Hurtubis C; Merkow RP; Franklin WA; Gonzalez R; Lewis K; Roaten JB; Robinson WA Am J Surg; 2006 Dec; 192(6):878-81. PubMed ID: 17161112 [TBL] [Abstract][Full Text] [Related]
14. In transit/local recurrences in melanoma patients after sentinel node biopsy and therapeutic lymph node dissection. Rutkowski P; Nowecki ZI; Zurawski Z; Dziewirski W; Nasierowska-Guttmejer A; Switaj T; Ruka W Eur J Cancer; 2006 Jan; 42(2):159-64. PubMed ID: 16324835 [TBL] [Abstract][Full Text] [Related]
17. Complete lymph node dissection for sentinel node-positive melanoma: assessment of practice patterns in the United States. Bilimoria KY; Balch CM; Bentrem DJ; Talamonti MS; Ko CY; Lange JR; Winchester DP; Wayne JD Ann Surg Oncol; 2008 Jun; 15(6):1566-76. PubMed ID: 18414952 [TBL] [Abstract][Full Text] [Related]
18. Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional study. Wong SL; Morton DL; Thompson JF; Gershenwald JE; Leong SP; Reintgen DS; Gutman H; Sabel MS; Carlson GW; McMasters KM; Tyler DS; Goydos JS; Eggermont AM; Nieweg OE; Cosimi AB; Riker AI; G Coit D Ann Surg Oncol; 2006 Jun; 13(6):809-16. PubMed ID: 16604476 [TBL] [Abstract][Full Text] [Related]
19. Criteria in sentinel lymph nodes of melanoma patients that predict involvement of nonsentinel lymph nodes. Satzger I; Völker B; Meier A; Kapp A; Gutzmer R Ann Surg Oncol; 2008 Jun; 15(6):1723-32. PubMed ID: 18389323 [TBL] [Abstract][Full Text] [Related]
20. Morbidity and recurrence after completion lymph node dissection following sentinel lymph node biopsy in cutaneous malignant melanoma. Guggenheim MM; Hug U; Jung FJ; Rousson V; Aust MC; Calcagni M; Künzi W; Giovanoli P Ann Surg; 2008 Apr; 247(4):687-93. PubMed ID: 18362633 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]